In conclusion, the present study demonstrates that MEK5/ERK5 overactivation contributes to colon cancer aggressiveness and therapy resistance, underlining the relevance of this cascade to the hallmarks of colon cancer. This evidence concerns the gene MAPK7 and malignant colon neoplasm.